Oracle CorporationORCLNYSE

Overview Intelligence Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 85% recommend buying.

Consensus Rating

Buy

33 analysts·High coverage

85%

Rating Distribution

Strong Buy

00%

Buy

2885%

Hold

515%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 98% higher.

Bear Case

$160.00

+7%

Consensus

$295.85

+98%

Bull Case

$400.00

+168%

Price Range33 analysts

Low

Consensus

High

$160.00

$400.00

Current Target

Current Price

$149.25

Upside to Target

$146.60

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$7.38(23 analysts)

P/E27x

Current: 27.0x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+29.44%

EPS+7.03%

FY2028

Rev+47.39%

EPS+33.88%

FY2029

Rev+44.59%

EPS+42.84%

Earnings Surprises

Beat rate:67%(8/12 quarters)

Avg surprise:+4.8%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Feb 9, 2026Melius Research

Oracle downgraded to Hold from Buy at Melius Research

Target:$160.00

+2.2%from $156.56

Feb 9, 2026Bernstein

Oracle price target lowered to $313 from $339 at Bernstein

Target:$313.00

+119.2%from $142.78

Feb 4, 2026BMO Capital

Oracle price target lowered to $205 from $270 at BMO Capital

Target:$205.00

+39.4%from $147.05

Feb 3, 2026Scotiabank

Oracle price target lowered to $220 from $260 at Scotiabank

Target:$220.00

+41.9%from $155.01

Feb 2, 2026Piper Sandler

Oracle price target lowered to $240 from $290 at Piper Sandler

Target:$240.00

+49.9%from $160.13

Jan 23, 2026Morgan Stanley

Oracle price target lowered to $213 from $320 at Morgan Stanley

Target:$213.00

+19.6%from $178.16

Jan 11, 2026Goldman Sachs

Oracle assumed with a Buy at Goldman Sachs

Target:$240.00

+20.9%from $198.52

Jan 5, 2026UBS

Oracle price target lowered to $280 from $325 at UBS

Target:$280.00

+42.8%from $196.11

Jan 5, 2026RBC Capital

Oracle price target lowered to $195 from $250 at RBC Capital

Target:$195.00

-0.4%from $195.71

Dec 15, 2025Mizuho Securities

Mizuho Reiterates Outperform Rating on Oracle (ORCL)

Target:$400.00

+111.0%from $189.59

Dec 12, 2025Goldman Sachs

Oracle price target lowered to $220 from $320 at Goldman Sachs

Target:$220.00

+10.8%from $198.64

Dec 11, 2025UBS

Oracle price target lowered to $325 from $380 at UBS

Target:$325.00

+68.7%from $192.66

Dec 11, 2025KeyBanc

Oracle (ORCL) PT Lowered to $300 at KeyBanc After 'Disapointing Results'

Target:$300.00

+56.1%from $192.13

Dec 11, 2025D.A. Davidson

Oracle price target lowered to $180 from $200 at DA Davidson

Target:$180.00

-5.2%from $189.94

Dec 11, 2025Cantor Fitzgerald

Oracle price target lowered to $320 from $400 at Cantor Fitzgerald

Target:$320.00

+68.8%from $189.62

Dec 11, 2025RBC Capital

Oracle price target lowered to $250 from $310 at RBC Capital

Target:$250.00

+12.0%from $223.31

Dec 11, 2025Stifel Nicolaus

Oracle price target lowered to $275 from $350 at Stifel

Target:$275.00

+23.1%from $223.31

Dec 11, 2025Barclays

Oracle price target lowered to $310 from $330 at Barclays

Target:$310.00

+38.8%from $223.31

Dec 11, 2025BMO Capital

Oracle price target lowered to $270 from $355 at BMO Capital

Target:$270.00

+20.9%from $223.31

Dec 11, 2025Scotiabank

Oracle (ORCL) PT Lowered to $260 at Scotiabank

Target:$260.00

+34.6%from $193.21

Dec 11, 2025Bernstein

Oracle price target lowered to $339 from $364 at Bernstein

Target:$339.00

+51.8%from $223.31

Dec 11, 2025Piper Sandler

Oracle price target lowered to $290 from $380 at Piper Sandler

Target:$290.00

+29.9%from $223.31

Dec 8, 2025Barclays

Oracle price target lowered to $330 from $400 at Barclays

Target:$330.00

+51.7%from $217.58

Dec 5, 2025RBC Capital

Oracle investor scrutiny growing, says RBC Capital

Target:$310.00

+42.7%from $217.17

Dec 3, 2025Wells Fargo

Oracle initiated with an Overweight at Wells Fargo

Target:$280.00

+39.2%from $201.10

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance